Tiered ICP Management Protocols

ABPN Neurocritical Care Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU

Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU

2 Chapter 2: Cerebral Physiology & Intracranial Dynamics

Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes

3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management

Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions

4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management

Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy

5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management

Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury

6 Chapter 6: Neuropharmacology, Analgesia & Sedation

ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU

7 Bleeding, Thrombosis & Hematologic Emergencies

Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity

8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine

Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention

9 Systemic Trauma & Environmental Injury

Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging

10 Cardiac Emergencies & Mechanical Support

IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies

11 Kidney Injury, Acid–Base & Renal Replacement

Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement

12 Systemic Infection & Endocrine Emergencies

Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies

13 Gastrointestinal & Hepatic Emergencies

Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects

14 Chapter 9: Neuroimaging in the Neuro-ICU

Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness

15 Chapter 10: Electrophysiology & Neuromonitoring

Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler

16 Angiography, Electrodiagnosis & CSF Analysis

Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage

17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria

Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria

18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies

Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction

19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage

Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH

20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia

Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations

21 Venous, Spinal & Traumatic Vascular Disease

Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury

22 Chapter 15: Traumatic Brain & Spinal Cord Injury

Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes

23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies

Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure

24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis

Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies

25 Neuroinflammation & Neurooncology

Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies

26 Pregnancy, Transplantation & Pediatric Care

Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care

27 Chapter 18: Neurosurgical & Perioperative Emergencies

Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies

28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU

Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor

Tiered ICP Management Protocols

Key Takeaways Explain This Topic AI

The Brain Trauma Foundation (BTF) 4th Edition establishes an intracranial pressure (ICP) treatment threshold of > 22 mmHg and a target cerebral perfusion pressure (CPP) of 60 to 70 mmHg.

CPP must be maintained >= 60 mmHg to prevent secondary ischemic injury, but aggressive elevation > 70 mmHg driven by fluids and vasopressors must be avoided due to high risk of ARDS.

Invasive ICP monitoring is indicated in severe TBI (GCS <= 8) with an abnormal CT scan, or with a normal CT scan if two or more risk factors are present: age > 40, motor posturing, or admission SBP < 90 mmHg.

Tier 0 baseline care enforces head of bed elevation at 30 degrees, neutral neck alignment, normothermia (< 37.5-38.0 °C), normal arterial blood gases (PaCO2 35-40 mmHg, PaO2 >= 80-100 mmHg), and isotonic maintenance fluids (0.9% normal saline).

Tier 1 interventions comprise intermittent cerebrospinal fluid (CSF) drainage via an external ventricular drain (EVD) leveled at the tragus, first-line hyperosmolar boluses, and brief mild hyperventilation (PaCO2 30-35 mmHg) strictly as an acute temporizing bridge.

Last updated: October 2026

Tiered Intracranial Pressure Management Protocols

Intracranial hypertension represents one of the most critical and time-sensitive emergencies encountered in the neurointensive care unit. In patients suffering from severe acute brain injury—including traumatic brain injury (TBI), large hemispheric ischemic stroke, aneurysmal subarachnoid hemorrhage (aSAH), and acute liver failure—uncontrolled elevations in intracranial pressure (ICP) lead directly to secondary ischemic infarction and fatal transtentorial or cerebellar herniation.

To standardize care and prevent therapeutic overshoot, modern neurocritical care utilizes a tiered escalation protocol. Rather than reacting haphazardly to elevated monitors, clinicians systematically deploy foundational neuroprotective baselines (Tier 0) before escalating to first-line therapies (Tier 1), reserving invasive medical and surgical interventions (Tiers 2 and 3) for truly refractory intracranial hypertension.

Indications for Invasive ICP Monitoring

Invasive intracranial pressure monitoring is not benign; catheter placement carries risks of tract hemorrhage (1–2%) and ventriculostomy-associated infection or ventriculitis (up to 5–10% with prolonged monitoring). Therefore, the BTF 4th edition recommends management informed by ICP monitoring in severe TBI and restates older selection criteria without new evidence meeting its updated standards. Traditional criteria for invasive ICP monitor placement in acute head injury:

Severe TBI with Abnormal Head CT : All patients with a post-resuscitation Glasgow Coma Scale (GCS) score ≤ 8 \le 8 ≤ 8 and an abnormal non-contrast admission head CT scan (demonstrating contusions, hematomas, cerebral edema, compressed basal cisterns, or midline shift) have an indication for invasive ICP monitoring.

Severe TBI with Normal Head CT (High-Risk Features) : Patients with severe TBI (GCS ≤ 8 \le 8 ≤ 8 ) and a normal initial head CT require invasive ICP monitoring if two or more of the following adverse features are present on admission:

• Age > 40 years
• Unilateral or bilateral motor posturing (decorticate or decerebrate posturing)
• Systolic blood pressure (SBP) < 90 mmHg

In this high-risk subset with a normal initial CT, approximately 60% will subsequently develop intracranial hypertension as contusions evolve or microvascular swelling progresses, compared to only 13% of severe TBI patients lacking these criteria.

Beyond TBI, invasive ICP monitoring is indicated in select non-traumatic cohorts: acute liver failure (ALF) presenting with Grade 3 or 4 hepatic encephalopathy (where hyperammonemic cytotoxic cerebral edema threatens brainstem herniation), large hemispheric infarction with malignant cerebral edema and depressed consciousness, and poor-grade aneurysmal subarachnoid hemorrhage or massive intraventricular hemorrhage complicated by acute obstructive hydrocephalus.

Note

A completely normal admission head CT scan does NOT exclude intracranial hypertension. Severe axonal injury, evolving contusions, and early microvascular dysregulation can cause delayed ICP spikes. Remember the "rule of two": age > 40, posturing, or SBP < 90 mmHg traditionally supports monitoring consideration in GCS ≤ 8 \le 8 ≤ 8 patients even when the initial CT appears unremarkable.

Brain Trauma Foundation 4th Edition Physiological Targets

The 4th Edition of the BTF guidelines established refined, evidence-based physiological thresholds that depart from historical dogma:

The ICP Treatment Threshold: > 22 mmHg

Historically, neurointensivists initiated therapy at an ICP cutoff of 20 mmHg. The BTF 4th Edition revised this recommendation to treat sustained ICP values > 22 mmHg (Level IIB recommendation). Prospective observational and retrospective analyses demonstrate that cumulative time exposure to ICP values above 22 mmHg correlates strongly with increased in-hospital mortality and worse 6-month functional outcomes on the Extended Glasgow Outcome Scale (GOS-E).

The Cerebral Perfusion Pressure (CPP) Equation and Target: 60–70 mmHg

Cerebral perfusion pressure represents the effective pressure gradient driving cerebral blood flow (CBF) across the cerebral vascular bed. It is defined mathematically as: C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP

(Note: If central venous pressure [CVP] exceeds ICP, CVP may replace ICP as the downstream pressure term in this simplified gradient: C P P = M A P − C V P CPP = MAP - CVP CPP = M A P − C V P .)

The recommended target for CPP is 60 to 70 mmHg (Level IIB recommendation). The boundaries of this range are clinically critical:

Avoid CPP < 60 mmHg : Values below 60 mmHg compromise microvascular collateral blood flow, precipitously increasing the risk of secondary cerebral ischemia, cellular bioenergetic failure, and infarct expansion.

Avoid Aggressive CPP > 70 mmHg : Historical paradigms (such as the Rosner protocol) advocated aggressive vasopressor titration and volume expansion to force CPP above 70 to 80 mmHg. Randomized clinical trials (notably Robertson et al.) proved that pushing CPP > 70 mmHg does not improve functional neurological outcomes and results in a five-fold increase in the incidence of acute respiratory distress syndrome (ARDS), hydrostatic pulmonary edema, and systemic cardiovascular complications.

Important

BTF recommends CPP 60–70 mm Hg for severe TBI, with the lower end individualized to autoregulatory status. Avoid aggressive fluid and pressor attempts to force CPP above 70 because of respiratory risk. The recommendation is not a universal prohibition on every observed CPP above 70 or a target for all nontraumatic injuries.

Tier 0: Foundational & Prophylactic Measures (Neuro-ICU Baseline)

Tier 0 consists of universal physiological optimization applied to all neurocritical care patients at risk for intracranial hypertension. These measures prevent iatrogenic ICP spikes and establish conditions for stable cerebral autoregulation:

Domain Intervention Physiological Rationale

Positioning Head of bed (HOB) elevated 30 ∘ 30^\circ 3 0 ∘ ; neutral neck alignment Facilitates internal jugular venous outflow and lowers intracranial venous pressure without dropping MAP

External Venous Return Avoid tight endotracheal tube (ETT) ties; loosen rigid cervical collars Eliminates extrinsic jugular vein compression that directly obstructs cerebral venous drainage

Analgesia & Sedation Short-acting opioids (fentanyl, remifentanil) and titratable sedatives (propofol) Blunts noxious airway stimulation, coughing, bucking, and paroxysmal sympathetic surges

Temperature Control Strict normothermia (treat core temp > 37.5 – 38.0 ∘ C > 37.5\text{--}38.0^\circ\text{C} > 37.5 – 38. 0 ∘ C with antipyretics and targeted cooling) Prevents hyperthermia-induced metabolic demand; C M R O 2 CMRO_2 CMR O 2 ​ increases 7–10% per 1 ∘ C 1^\circ\text{C} 1 ∘ C rise, causing cerebral hyperemia

Ventilation & Blood Gas P a C O 2 35 – 45 mmHg PaCO_2\ 35\text{--}45\text{ mmHg} P a C O 2 ​ 35 – 45 mmHg ; P a O 2 ≥ 80 – 100 mmHg PaO_2 \ge 80\text{--}100\text{ mmHg} P a O 2 ​ ≥ 80 – 100 mmHg ( S p O 2 ≥ 95 % SpO_2 \ge 95\% Sp O 2 ​ ≥ 95% ) Prevents C O 2 CO_2 C O 2 ​ -mediated vasodilation; avoids hypoxemic cerebral vasodilation ( P a O 2 < 60 mmHg PaO_2 < 60\text{ mmHg} P a O 2 ​ < 60 mmHg )

Intravenous Fluid Selection Isotonic crystalloids ( 0.9 % 0.9\% 0.9% Normal Saline, 308 mOsm/L 308\text{ mOsm/L} 308 mOsm/L ) Strictly avoids hypotonic fluids ( 0.45 % 0.45\% 0.45% NaCl, Lactated Ringer's, D 5 W D_5W D 5 ​ W ) that drive cerebral edema

Warning

Avoid routine hypotonic maintenance fluid in acute brain swelling. Fluid choice also depends on shock, sodium, acid–base status, and the specific indication. Saline is commonly favored in severe TBI; do not withhold emergency glucose or needed resuscitation, or prohibit a specifically prescribed free-water correction plan for hypernatremia.

Tier 1 Interventions: Active First-Line Escalation

When intracranial pressure exceeds 22 mmHg for greater than 5 to 10 minutes despite optimized Tier 0 measures, clinicians escalate to Tier 1 interventions:

1. Intermittent CSF Drainage via External Ventricular Drain (EVD)

Placement of an external ventricular drain (ventriculostomy) remains the gold standard for both therapeutic and diagnostic management. The transducer must be leveled precisely at the foramen of Monro , externally referenced to the tragus of the ear or external auditory meatus.

Drainage protocols: Continuous and intermittent approaches depend on disease and local protocol. BTF notes that continuous drainage may lower ICP burden more effectively in selected severe TBI. Standard single-lumen systems usually need drainage temporarily closed for a valid pressure reading. Relevel after position changes and avoid uncontrolled drainage.

2. First-Line Hyperosmolar Therapy

Intravenous boluses of hyperosmolar agents draw excess interstitial water from intact brain parenchyma into the intravascular compartment. Options include:

Mannitol 20% : 0.25 to 1.0 g/kg 0.25\text{ to }1.0\text{ g/kg} 0.25 to 1.0 g/kg IV bolus administered over 15–20 minutes.

Hypertonic Saline (HTS) 3% : 250 to 500 mL 250\text{ to }500\text{ mL} 250 to 500 mL IV bolus over 15–30 minutes.

3. Titration of Analgesia and Sedation

Short-acting titratable infusions (such as propofol or remifentanil) are deepened to suppress ventilator dyssynchrony, tachypnea, and posturing reflexes. Propofol carries the added benefit of lowering the cerebral metabolic rate of oxygen ( C M R O 2 CMRO_2 CMR O 2 ​ ) and cerebral blood volume, but must be monitored closely to avoid systemic hypotension.

4. Brief Mild Hyperventilation as a Bridge Only

Controlled mild hyperventilation to a target P a C O 2 PaCO_2 P a C O 2 ​ of 30 to 35 mmHg induces acute precapillary arteriolar vasoconstriction, rapidly reducing cerebral blood volume and ICP. However, hyperventilation must be used strictly as an acute, temporary bridge (minutes to a few hours) while preparing definitive interventions (such as mass lesion evacuation or osmotherapy). Prolonged hypocapnia induces severe cerebral vasoconstriction, microvascular hypoperfusion, and penumbral tissue ischemia.